TABLE 1.

Information about the subjects included in the monoclonal antibody study (age, gender, and vaccine received)

Subject ID	Age (yr)	Genderb	Vaccine	HAI titersa
				A/California/2009 H1N1			A/Switzerland/2013 H3N2			B/Phuket/2013
				d0	d28	Fold change	d0	d28	Fold change	d0	d28	Fold change
150055-003	21	F	Flublok	1,280	1,280	1	80	1,280	16	320	640	2
150055-008	47	F	Flublok	10	640	64	10	640	64	80	320	4
150055-010	20	F	Flublok	320	2,560	8	20	2,560	128	20	40	2
150055-023	30	M	Flublok
150055-032	19	M	Flublok	20	2,560	128	40	10,240	256	40	160	4
150055-037	20	F	Flublok	40	2,560	64	40	1,280	32	40	1,280	32
150055-001	30	M	Flucelvax	20	320	16	10	20	2	40	80	2
150055-005	19	F	Flucelvax	10	160	16	10	1,280	128	160	640	4
150055-011	29	F	Flucelvax	320	640	2	640	1,280	2	40	160	4
150055-015	31	M	Flucelvax	20	2,560	128	320	1,280	4	10	640	64
150055-029	42	M	Flucelvax	320	2,560	8	80	320	4	640	640	1

^aAbsolute serum HAI titers at d0 and d28 as well as fold changes are presented for each virus strain (H1N1, H3N2, and B strain). Titers could not be determined for one individual (150055-023).

^bF, female; M, male.